MedTrace Logo

Vinegar Co-ingestion in Type 2 Diabetes

NCT01279317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-10-03

Study results available
· View outcomes & findings →

Summary

The main objective of this study is to assess the acute effect of co-ingested vinegar on postprandial plasma glucose levels in type 2 diabetes patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

placebo co-ingestion

25 ml water co-ingested with a glucose-containing beverage

DIETARY_SUPPLEMENT

vinegar co-ingestion

25 ml vinegar (1 g acetic acid) co-ingested with a glucose-containing beverage

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279317 on ClinicalTrials.gov